Eaton Vance Management’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $3.03M | Buy |
27,375
+4,978
| +22% | +$550K | ﹤0.01% | 917 |
|
|
2022
Q2 | $1.68M | Buy |
22,397
+6,009
| +37% | +$450K | ﹤0.01% | 1131 |
|
|
2022
Q1 | $1.28M | Buy |
16,388
+16,060
| +4,896% | +$1.25M | ﹤0.01% | 1306 |
|
|
2021
Q4 | $30K | Hold |
328
| – | – | ﹤0.01% | 2281 |
|
|
2021
Q3 | $0 | Buy |
+328
| New | – | ﹤0.01% | 2619 |
|
|
2021
Q2 | – | Sell |
-1,832
| Closed | -$137K | – | 3008 |
|
|
2021
Q1 | $137K | Buy |
+1,832
| New | +$137K | ﹤0.01% | 1540 |
|
|
2019
Q3 | – | Sell |
-134,235
| Closed | -$20.4M | – | 1314 |
|
|
2019
Q2 | $20.4M | Buy |
134,235
+7
| +0% | +$1.06K | 0.04% | 302 |
|
|
2019
Q1 | $16M | Buy |
134,228
+22,454
| +20% | +$2.68M | 0.04% | 323 |
|
|
2018
Q4 | $12.2M | Buy |
+111,774
| New | +$12.2M | 0.03% | 331 |
|